TY - JOUR
T1 - Programmable RNA Loading of Extracellular Vesicles with Toehold-Release Purification
AU - Malle, Mette Galsgaard
AU - Song, Ping
AU - Löffler, Philipp M.G.
AU - Kalisi, Nazmie
AU - Yan, Yan
AU - Valero, Julián
AU - Vogel, Stefan
AU - Kjems, Jørgen
PY - 2024/5
Y1 - 2024/5
N2 - Synthetic nanoparticles as lipid nanoparticles (LNPs) are widely used as drug delivery vesicles. However, they hold several drawbacks, including low biocompatibility and unfavorable immune responses. Naturally occurring extracellular vesicles (EVs) hold the potential as native, safe, and multifunctional nanovesicle carriers. However, loading of EVs with large biomolecules remains a challenge. Here, we present a controlled loading methodology using DNA-mediated and programmed fusion between EVs and messenger RNA (mRNA)-loaded liposomes. The fusion efficiency is characterized at the single-particle level by real-time microscopy through EV surface immobilization via lipidated biotin-DNA handles. Subsequently, fused EV−liposome particles (EVLs) can be collected by employing a DNA strand-replacement reaction. Transferring the fusion reaction to magnetic beads enables us to scale up the production of EVLs one million times. Finally, we demonstrated encapsulation of mCherry mRNA, transfection, and improved translation using the EVLs compared to liposomes or LNPs in HEK293-H cells. We envision this as an important tool for the EV-mediated delivery of RNA therapeutics.
AB - Synthetic nanoparticles as lipid nanoparticles (LNPs) are widely used as drug delivery vesicles. However, they hold several drawbacks, including low biocompatibility and unfavorable immune responses. Naturally occurring extracellular vesicles (EVs) hold the potential as native, safe, and multifunctional nanovesicle carriers. However, loading of EVs with large biomolecules remains a challenge. Here, we present a controlled loading methodology using DNA-mediated and programmed fusion between EVs and messenger RNA (mRNA)-loaded liposomes. The fusion efficiency is characterized at the single-particle level by real-time microscopy through EV surface immobilization via lipidated biotin-DNA handles. Subsequently, fused EV−liposome particles (EVLs) can be collected by employing a DNA strand-replacement reaction. Transferring the fusion reaction to magnetic beads enables us to scale up the production of EVLs one million times. Finally, we demonstrated encapsulation of mCherry mRNA, transfection, and improved translation using the EVLs compared to liposomes or LNPs in HEK293-H cells. We envision this as an important tool for the EV-mediated delivery of RNA therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=85191787511&partnerID=8YFLogxK
U2 - 10.1021/JACS.3C13123
DO - 10.1021/JACS.3C13123
M3 - Journal article
C2 - 38669207
AN - SCOPUS:85191787511
SN - 0002-7863
VL - 146
SP - 12410
EP - 12422
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 18
ER -